Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Table A3. Healthy People 2020 (HP 2020) Sexually Transmitted Disease Objectives

 
This web page is archived for historical purposes and is no longer being updated. Newer data is available on the 

STD Data and Statistics page.
 

HP2020 ObjectivesBaseline YearBaseline201120122013HP 2020 Target
1 Reduce the proportion of adolescents and young adults with Chlamydia trachomatis infectionsa. Among females aged 15 to 24 years attending family planning clinics20087.4%8.3%N/AN/A6.7%
b. Among females aged 24 years and under enrolled in a National Job Training Program200812.8%10.4%11.0%11.7%11.5%
c. Among males aged 24 years and under enrolled in a National Job Training Program20087.0%8.0%7.0%7.4%6.3%
2 Increase the proportion of sexually active females aged 24 years and under enrolled in Medicaid plans who are screened for genital Chlamydia infections during the measurement yeara. Females aged 16 to 20 years200852.7%54.9%53.5%N/A70.9%
b. Females aged 21 to 24 years200859.4%63.4%63.6%N/A80.0%
3 Increase the proportion of sexually active females aged 24 years and under enrolled in commercial health insurance plans who are screened for genital Chlamydia infections during the measurement yeara. Females aged 16 to 20 years200840.1%41.5%41.4%N/A61.3%
b. Females aged 21 to 24 years200843.5%48.4%49.2%N/A74.6%
4 Reduce the proportion of females aged 15 to 44 who have ever required treatment for pelvic inflammatory disease (PID)2006-20084.0%N/AN/AN/A3.6%
5 Reduce gonorrhea rates (cases per 100,000 population)a. Females aged 15 to 44 years2008285.0264.8264.7250.6257.0
b. Males aged 15 to 44 years2008220.4217.7232.1239.4198.0
6 Reduce sustained domestic transmission of primary and secondary syphilis (cases per 100,000 population)a. Among females20081.50.90.90.91.4
b. Among males20087.58.19.310.36.8
7 Reduce congenital syphilis200810.58.77.88.79.1
8 Reduce the proportion of females with human papillomavirus (HPV) Infection (DEVELOPMENTAL)a. Females with types 6 and 112003-20063.2N/AN/AN/AN/A
b. Females with types 16 and 182003-20066.2N/AN/AN/AN/A
c. Females with other types2003-200640.3N/AN/AN/AN/A
9 Reduce the proportion of young adults with genital herpes infection due to herpes simplex type 22005-200810.5%8.3%*N/A9.5%
 
HP2020 ObjectivesData Source
1 aNational Notifiable Disease Surveillance System (NNDSS), NCHHSTP, CDC
1b, 1cNational Job Training Program, STD Surveillance System (STDSS), NCHHSTP, CDC
2a, 2bHealthcare Effectiveness Data and Information Set (HEDIS), National Committee for Quality Assurance (NCQA)
3a, 3bHealthcare Effectiveness Data and Information Set (HEDIS), National Committee for Quality Assurance (NCQA)
42006-2010 National Survey of Family Growth (NSFG), NCHS, CDC
5a, 5bSTD Surveillance System (STDSS), NCHHSTP, CDC
6a, 6bSTD Surveillance System (STDSS), NCHHSTP, CDC
7STD Surveillance System (STDSS), NCHHSTP, CDC
8a, 8bNHANES, CDC, NCHS and the National Health Interview Survey (NHIS), CDC
8cNHANES, CDC, NCHS
9NHANES, CDC, NCHS

*         The HSV seroprevalence for 20–29 year olds is reported for years 2011–2012. Data from each individual year is not available.

Next table

Top